Revised Status Indicator for HCPCS Code Q5101
Effective Sept. 3, 2015, the status indicator for HCPCS Level II code Q5101 Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram has changed from E Not paid by Medicare when submitted on outpatient claims (any outpatient bill type) to K Paid under OPPS; separate APC payment.
This change is effective Oct. 1, 2015.
The Centers for Medicare & Medicaid Services (CMS) notified Medicare administrative contractors (MAC) in Transmittal 3352 of this change, and it is in the October update of the Integrated Outpatient Code Editor (I/OCE).
If you had claims for Q5101 with dates of service on or after Sept. 3, 2015, that were processed prior to the installation of the October 2015 Outpatient Prospective Payment System Pricer, you can request that those claims be adjusted by your MAC.
Source: MLN Matters® MM9298 Revised
Latest posts by Renee Dustman (see all)
- 2018 MPFS Proposed Rule Eases Reporting Criteria - July 19, 2017
- CMS to Implement Advanced Diagnostic Imaging Monitoring Program - July 17, 2017
- Breaking News: 2018 MPFS Proposed Rule - July 14, 2017